250 related articles for article (PubMed ID: 32123491)
41. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
42. [Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy].
Gui L; Shi Y; He X; Zhou L; Dong M; Zhou S; Yuan P; Liu P; Yang J; Zhang C; Qin Y; Yang S
Zhonghua Yi Xue Za Zhi; 2015 Feb; 95(6):425-9. PubMed ID: 25916778
[TBL] [Abstract][Full Text] [Related]
43. Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma.
Macintyre E; Willerford D; Morris SW
Hematology Am Soc Hematol Educ Program; 2000; ():180-204. PubMed ID: 11701542
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
[TBL] [Abstract][Full Text] [Related]
45. Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas.
Breinholt MF; Schejbel L; Gang AO; Nielsen TH; Pedersen LM; Høgdall E; Nørgaard P
Eur J Haematol; 2023 Oct; 111(4):583-591. PubMed ID: 37452559
[TBL] [Abstract][Full Text] [Related]
46. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
47. Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma.
Mahmoud HM; El-Sakhawy YN
Hematol Rep; 2011 Oct; 3(3):e26. PubMed ID: 22593817
[TBL] [Abstract][Full Text] [Related]
48. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
Naresh KN; Srinivas V; Soman CS
Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
[TBL] [Abstract][Full Text] [Related]
49. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
Porcu P; Nichols CR
Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
[TBL] [Abstract][Full Text] [Related]
50. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
52. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
53. New developments in extracutaneous lymphomas.
Chott A; Raderer M
Semin Cutan Med Surg; 2000 Jun; 19(2):149-56. PubMed ID: 10892718
[TBL] [Abstract][Full Text] [Related]
54. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Naushad H; Bi C; Yu J; Bouska A; Rohr J; Chao W; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):73-88. PubMed ID: 26432520
[TBL] [Abstract][Full Text] [Related]
55. Non-Hodgkin's lymphoma classification: ultrastructural morphometric studies for the quantification of nuclear compartments in situ.
Dardick I; Dardick AM; Caldwell DR; Jeans MT; Bladon T; Setterfield G
Hum Pathol; 1985 Oct; 16(10):1047-60. PubMed ID: 4043954
[TBL] [Abstract][Full Text] [Related]
56. Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma.
Ohno H
Histol Histopathol; 2004 Apr; 19(2):637-50. PubMed ID: 15024721
[TBL] [Abstract][Full Text] [Related]
57. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
[TBL] [Abstract][Full Text] [Related]
58. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
59. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
60. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
